Zobrazeno 101 - 110
of 340
pro vyhledávání: '"Giuseppe Castellano"'
Autor:
Simone Vettoretti, Lara Caldiroli, Silvia Armelloni, Deborah Mattinzoli, Masami Ikehata, Paolo Molinari, Carlo Alfieri, Piergiorgio Messa, Giuseppe Castellano
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Current guidelines do not clarify whether older patients with advanced chronic kidney disease may benefit of low protein diet if they are at risk of malnutrition. We compared the effects of normo-calorie/normo-protein (NP) and nor
Publikováno v:
MANAGEMENT CONTROL. :129-150
Autor:
Simona Simone, Giuseppe Grandaliano, Giuseppe Castellano, Barbara Infante, Giovanni Pertosa, Paola Pontrelli, Loreto Gesualdo, Federica Rascio, Annarita Chieti, Giovanni Stallone
Publikováno v:
Journal of Nephrology
Background Hemodialysis patients present a dramatic increase in cardiovascular morbidity/mortality. Circulating immune cells, activated by both uremic milieu and dialysis, play a key role in the pathogenesis of dialysis-related vascular disease. The
Publikováno v:
International urology and nephrology. 55(1)
In tunnel infection (TI) refractory to medical therapy or in case of TI that occurs simultaneously with peritonitis, the removal of the peritoneal catheter has been proposed. This approach requires the interruption of peritoneal dialysis (PD) and the
Autor:
Carlo Alfieri, Silvia Malvica, Matteo Cesari, Simone Vettoretti, Matteo Benedetti, Elisa Cicero, Roberta Miglio, Lara Caldiroli, Alessandro Perna, Angela Cervesato, Giuseppe Castellano
Publikováno v:
Clinical kidney journal. 15(11)
The problem of frailty in kidney transplantation is an increasingly discussed topic in the transplant field, partially also generated by the multiple comorbidities by which these patients are affected. The criteria currently used to establish the pre
Autor:
Dario Troise, Giuseppe Castellano, Barbara Infante, Matteo Gravina, Nicola Coviello, Valeria Bux, Giovanni Stallone
Publikováno v:
Kidney & Blood Pressure Research, Vol 46, Iss 1, Pp 121-125 (2021)
Introduction: The immunosuppressive efficiency obtained in the last decades in kidney transplantation significantly improved graft survival. However, there is still a high risk and incidence of cancer in transplant patients strongly and directly rela
Autor:
Giuseppe Castellano, Giovanni Stallone, Loreto Gesualdo, Mauro Forcella, Barbara Infante, Sharon Cox, Gaetano Serviddio, Silvia Mercuri
Publikováno v:
Journal of Nephrology
Autor:
Angela Picerno, Giuseppe Castellano, Claudia Curci, Katarzyna Kopaczka, Alessandra Stasi, Giovanni Battista Pertosa, Carlo Sabbà, Loreto Gesualdo, Roberto Gramignoli, Fabio Sallustio
Publikováno v:
Frontiers in immunology. 13
Our immune system actively fights bacteria and viruses, and it must strike a delicate balance between over- and under-reaction, just like Daedalus and Icarus in Greek mythology, who could not escape their imprisonment by flying too high or too low. B
Autor:
Luca, Nardelli, Antonio, Scalamogna, Maurizio, Gallieni, Evaldo, Favi, Piergiorgio, Messa, Giuseppe, Castellano
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 38(6)
Kidney transplantation is the gold-standard treatment of end-stage renal disease. Receiving a pre-emptive transplant ensures the best survival for both the recipient and the allograft. However, due to an overwhelming discrepancy between available don
Autor:
Luca Nardelli, Antonio Scalamogna, Piergiorgio Messa, Maurizio Gallieni, Roberto Cacciola, Federica Tripodi, Giuseppe Castellano, Evaldo Favi
Publikováno v:
Medicina (Kaunas, Lithuania). 58(2)
Kidney transplantation (KT) is recognized as the gold-standard of treatment for patients with end-stage renal disease. Additionally, it has been demonstrated that receiving a pre-emptive KT ensures the best recipient and graft survivals. However, due